Background
The advent of antiretroviral therapy has led to increased life span which has been associated with an increase in cardiovascular risk factors and heart disease (Boccara F et al, 2013 [1]). Cardiovascular risk assessment is now advised for those with HIV. The field of behavioural cardiology is particularly applicable in HIV therapy due to the long term nature of such a condition. Therefore, it’s useful to assess behaviour modifications following comprehensive cardiac evaluation, specifically CMRI.